Adam Linck
Family Medicine · Casper, WYNPI 1093026882
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 102 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 36.2% of the total. Reporting peaked in 2022 at $540 and has fallen 65.3% since, to $187 in 2025.
Across 102 payments — averaging $18.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$671
- Amgen$240
- Bayer$89
- Lilly USA, LLC$85
- Pfizer$79
- Novo Nordisk$77
- plus $615 from 18 others
What the payments were for
- Food & beverage$1,80097%
- Education$553%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 33 | $671 |
| Amgen | 16 | $240 |
| Bayer | 6 | $89 |
| Lilly USA, LLC | 5 | $85 |
| Pfizer | 4 | $79 |
| Novo Nordisk | 4 | $77 |
| Actelion Pharmaceuticals US, Inc. | 2 | $76 |
| Exact Sciences | 4 | $72 |
| Boehringer Ingelheim | 4 | $60 |
| Merck | 4 | $54 |
| Johnson & Johnson | 2 | $49 |
| Abbott | 2 | $43 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| Ultragenyx Pharmaceutical Inc. | 2 | $33 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Astellas Pharma US Inc | 1 | $27 |
| GSK | 2 | $25 |
| Novartis | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Ascensia Diabetes Care US Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| AstraZeneca | 1 | $13 |
How this compares
$1,855 in reported general payments places this provider in the 85th percentile of 237 family medicine providers in Wyoming.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Losartan Potassium | 13 | $127 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Casper
- Joseph SchoeberCasper$176K
- James McLennanCasper$13K
- Karlynn SieversCasper$10K
- Eric LawrenceCasper$7K
- Louis RoussalisCasper$5K
- Joseph MickelsonCasper$5K
- Jonathan BinderCasper$4K
- Sherrill FoxCasper$4K
- Taylor PedersenCasper$4K
- Tiffany SpauldingCasper$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.